Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,074,198
+$68,124,726 QoQ
Shares Held
1,267,706
+45.2% QoQ
Ownership
1.42%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#14
of 333 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Jun 30, 2026CallValue
$7,215,565
CallShares
90,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in LQDA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,074,198 | 1,267,706 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $7,215,565 | 90,500 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $32,949,472 | 873,065 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,366,188 | 36,200 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $57,508,004 | 1,667,382 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $4,311,250 | 125,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $33,834,867 | 1,487,901 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,824,629 | 146,439 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,424,516 | 164,374 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $142,260 | 12,097 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $167,376 | 13,948 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $357,304 | 24,224 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $615,190 | 51,138 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $112,788 | 14,368 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $2,084,755 | 478,155 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,510,429 | 349,642 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,796,294 | 368,849 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $475,876 | 172,419 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $416,506 | 145,632 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $125,598 | 46,691 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $106,536 | 36,114 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||